227 related articles for article (PubMed ID: 32047539)
1. Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer.
Wei J; Yang L; Wu YN; Xu J
J Cancer; 2020; 11(6):1325-1333. PubMed ID: 32047539
[No Abstract] [Full Text] [Related]
2. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
[TBL] [Abstract][Full Text] [Related]
3. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
Liu J; Gao J; Du Y; Li Z; Ren Y; Gu J; Wang X; Gong Y; Wang W; Kong X
Int J Cancer; 2012 Aug; 131(3):683-91. PubMed ID: 21913185
[TBL] [Abstract][Full Text] [Related]
4. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.
Jahan R; Ganguly K; Smith LM; Atri P; Carmicheal J; Sheinin Y; Rachagani S; Natarajan G; Brand RE; Macha MA; Grandgenett PM; Kaur S; Batra SK
EBioMedicine; 2019 Apr; 42():375-385. PubMed ID: 30956167
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.
Lin MS; Chen WC; Huang JX; Gao HJ; Sheng HH
Int J Clin Exp Med; 2014; 7(12):5226-34. PubMed ID: 25664025
[TBL] [Abstract][Full Text] [Related]
6. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
7. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer.
Shi W; Lu Y; Gong R; Sun JJ; Liu G
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5187-5193. PubMed ID: 30178840
[TBL] [Abstract][Full Text] [Related]
9. New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer.
Yuan W; Tang W; Xie Y; Wang S; Chen Y; Qi J; Qiao Y; Ma J
Oncotarget; 2016 Nov; 7(48):80033-80045. PubMed ID: 27713117
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
11. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients.
Zhong A; Qin R; Qin W; Han J; Gu Y; Zhou L; Zhang H; Ren S; Lu R; Guo L; Gu J
Front Oncol; 2019; 9():114. PubMed ID: 30873386
[No Abstract] [Full Text] [Related]
13. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
15. Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study.
Xu J; Cao Z; Liu W; You L; Zhou L; Wang C; Lou W; Sun B; Miao Y; Liu X; Zhang T; Zhao Y
Ann Surg; 2016 Jun; 263(6):1173-9. PubMed ID: 26114496
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.
Li A; Yu J; Kim H; Wolfgang CL; Canto MI; Hruban RH; Goggins M
Clin Cancer Res; 2013 Jul; 19(13):3600-10. PubMed ID: 23697990
[TBL] [Abstract][Full Text] [Related]
17. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
18. Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer.
Yu Y; Tong Y; Zhong A; Wang Y; Lu R; Guo L
Medicine (Baltimore); 2020 Dec; 99(52):e23863. PubMed ID: 33350781
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.
Ritchie SA; Chitou B; Zheng Q; Jayasinghe D; Jin W; Mochizuki A; Goodenowe DB
World J Gastroenterol; 2015 Jun; 21(21):6604-12. PubMed ID: 26074698
[TBL] [Abstract][Full Text] [Related]
20. The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis.
Vieira NF; Serafini LN; Novais PC; Neto FSL; Cirino MLA; Kemp R; Ardengh JC; Saggioro FP; Gaspar AF; Sankarankutty AK; Júnior JRL; Tirapelli DPDC; Dos Santos JS
Oncotarget; 2021 Aug; 12(17):1638-1650. PubMed ID: 34434493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
